Haemonetics Corporation

HAE · NYSE
Analyze with AI
$79.98−$1.13 (−1.39%)
At close:Dec 17, 2025, 9:00 PM UTC
$79.98+$0.00 (+0%)
After hours:Dec 17, 2025, 11:27 PM UTC
P/E TTM22.63
P/B TTM4.48
P/S TTM2.94
Dividend Yield0%
EPS$3.38
Beta0.3
Valuation
PEG Ratio4.96
FCF Yield6.56%
EV / EBITDA14.91
More On Valuation »
Quality
ROIC8.60%
Gross Margin57.37%
Cash Conv. Ratio1.72
More On Quality »
Growth
Revenue 3Y CAGR5.21%
FCF Growth23.38%
More On Growth »
Safety
Net Debt / EBITDA2.86
Interest Coverage37.10
More On Safety »
Efficiency
Inventory Turnover1.68
Cash Conv. Cycle233.93
More On Efficiency »

Haemonetics Corporation (HAE) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Haemonetics Corporation (HAE) stock price today?

As of Dec 17, 2025, 9:00 PM UTC, Haemonetics Corporation (HAE) stock is trading at $79.98. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date HAE stock quotes for informed trading decisions.

What is Haemonetics Corporation's market capitalization?

Haemonetics Corporation (HAE) has a market capitalization of approximately $3.9B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Haemonetics Corporation's size relative to other companies in the USD market. The market cap figure updates automatically as the HAE stock price changes.

What is the 52-week range for Haemonetics Corporation stock?

Haemonetics Corporation (HAE) stock has traded in a 52-week range of $47.32 — $87.32. The 52-week range shows the highest and lowest prices at which HAE traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Haemonetics Corporation stock price to this range provides context for recent price action.

How much trading volume does Haemonetics Corporation stock have?

Haemonetics Corporation (HAE) stock recently traded approximately 762.8K shares. Trading volume indicates market liquidity and investor interest in HAE. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Haemonetics Corporation stock.

Does Haemonetics Corporation pay dividends to shareholders?

Yes, Haemonetics Corporation (HAE) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Haemonetics Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Haemonetics Corporation's intraday price range?

Today, Haemonetics Corporation (HAE) stock has traded in a range of $79.23 — $82.41. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring HAE's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Haemonetics Corporation stock data?

AlphaPilot sources real-time HAE stock quotes, fundamental financial data, and historical price charts for Haemonetics Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Haemonetics Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of HAE stock performance.